Loading…
Kothari Fermentation & Biochem (BSE 507474)₹42.40+5.66%Other Food Products
In the Mar 2026 quarter (standalone), Kothari Fermentation & Biochem reported sales of ₹32.41 Cr, up 1.0% from Mar 2025, and net profit of ₹1.26 Cr, up 21.2% year on year. For the year to Mar 2026, sales were ₹112 Cr and net profit −₹2.99 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 25.55 | 22.65 | 28.52 | 31.92 | 26.32 | 25.09 | 30.45 | 32.10 | 23.71 | 23.89 | 31.88 | 32.41 |
| Expenses | 26.14 | 24.06 | 25.94 | 27.86 | 23.03 | 24.33 | 27.39 | 27.79 | 22.15 | 24.45 | 29.65 | 29.65 |
| Operating Profit | −0.46 | −1.31 | 2.70 | 4.21 | 3.38 | 0.87 | 3.17 | 4.42 | 1.65 | −0.44 | 2.37 | 2.90 |
| OPM % | −1.8% | −5.8% | 9.5% | 13.2% | 12.9% | 3.5% | 10.5% | 13.8% | 7.0% | −1.9% | 7.5% | 9.0% |
| Other Income | 0.00 | 0.02 | 0.00 | 0.01 | 0.05 | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 | 0.72 |
| Interest | 0.83 | 0.83 | 0.84 | 0.95 | 0.87 | 0.82 | 0.84 | 1.02 | 0.79 | 0.89 | 0.90 | 1.08 |
| Depreciation | 1.39 | 1.40 | 1.40 | 1.40 | 1.60 | 1.60 | 1.60 | 1.60 | 1.74 | 1.74 | 1.74 | 1.74 |
| Profit before tax | −2.70 | −3.53 | 0.44 | 1.86 | 0.95 | −1.55 | 0.71 | 1.81 | −0.88 | −3.09 | −0.26 | 0.79 |
| Tax % | −0.7% | −2.0% | 15.5% | 53.5% | −14.6% | 12.1% | 43.0% | 41.8% | 26.9% | −0.7% | 40.7% | −58.8% |
| Net Profit | −2.68 | −3.46 | 0.37 | 0.86 | 1.09 | −1.74 | 0.40 | 1.04 | −1.11 | −3.07 | −0.37 | 1.26 |
| EPS (Rs) | −1.78 | −2.30 | 0.24 | 0.57 | 0.72 | −1.16 | 0.26 | 0.69 | −0.74 | −2.04 | −0.24 | 0.84 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 76.86 | 78.86 | 87.79 | 95.70 | 96.84 | 95.83 | 96.84 | 110 | 109 | 114 | 112 | 112 |
| Expenses | 71.16 | 70.11 | 76.20 | 78.19 | 82.20 | 81.25 | 87.26 | 101 | 104 | 102 | 106 | 106 |
| Operating Profit | 5.98 | 8.97 | 11.97 | 17.95 | 14.95 | 13.97 | 9.97 | 8.98 | 4.99 | 11.97 | 5.99 | 6.48 |
| OPM % | 8.1% | 11.1% | 14.0% | 18.0% | 15.0% | 15.0% | 11.0% | 8.0% | 4.7% | 10.1% | 6.0% | 5.8% |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 2.99 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.99 | 0.72 |
| Interest | 0.99 | 1.99 | 1.99 | 1.99 | 1.99 | 3.99 | 2.99 | 2.99 | 3.99 | 3.99 | 3.99 | 3.66 |
| Depreciation | 1.99 | 2.99 | 2.99 | 3.99 | 3.99 | 4.98 | 5.99 | 5.99 | 5.99 | 5.99 | 6.98 | 6.96 |
| Profit before tax | 2.99 | 4.98 | 6.97 | 11.95 | 10.96 | 5.98 | 1.99 | 0.00 | −3.98 | 1.99 | −2.99 | −3.44 |
| Tax % | 34.0% | 34.0% | 26.0% | 30.0% | 30.0% | 17.0% | 79.0% | 34.0% | 25.0% | 58.0% | −14.0% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Profit | 1.99 | 2.99 | 4.99 | 8.98 | 7.99 | 4.99 | 0.00 | 0.00 | −4.99 | 0.99 | −2.99 | −3.29 |
| EPS (Rs) | 1.25 | 2.13 | 3.54 | 5.80 | 5.10 | 3.20 | 0.20 | 0.12 | −3.26 | 0.53 | −1.98 | −2.18 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 14.99 | 14.99 | 14.98 | 14.99 | 14.99 | 15.01 | 14.99 | 15.01 | 14.99 | 14.99 | 14.99 | 14.99 |
| Reserves | 14.04 | 16.05 | 19.06 | 24.04 | 33.08 | 41.08 | 45.10 | 46.15 | 46.12 | 41.07 | 42.10 | 39.07 |
| Borrowings | 11.95 | 15.93 | 17.92 | 15.94 | 22.93 | 33.90 | 38.84 | 44.85 | 44.86 | 46.82 | 42.82 | 47.85 |
| Other Liabilities | 8.03 | 10.02 | 13.04 | 12.00 | 14.97 | 16.03 | 17.04 | 22.97 | 26.00 | 29.07 | 28.02 | 25.08 |
| Total Liabilities | 49.01 | 56.99 | 65.00 | 66.97 | 85.97 | 106 | 116 | 129 | 131 | 132 | 128 | 127 |
| Fixed Assets | 23.98 | 33.95 | 42.97 | 51.94 | 51.93 | 73.95 | 81.93 | 79.93 | 73.90 | 86.85 | 91.88 | 84.94 |
| CWIP | 6.01 | 7.01 | 6.01 | 1.01 | 14.02 | 3.01 | 7.01 | 16.01 | 19.03 | 8.01 | 0.00 | 6.01 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 19.02 | 16.03 | 17.02 | 15.02 | 20.02 | 29.06 | 28.03 | 33.04 | 38.04 | 37.09 | 36.05 | 36.04 |
| Inventories | 5.47 | 6.00 | 6.52 | 5.07 | 8.09 | 15.43 | 14.43 | 18.13 | 22.40 | 20.96 | 23.45 | 23.20 |
| Trade receivables | 4.16 | 4.56 | 5.30 | 5.38 | 6.90 | 7.58 | 6.18 | 5.67 | 7.82 | 9.07 | 9.48 | 6.28 |
| Cash & equivalents | 1.53 | 0.72 | 0.76 | 0.96 | 0.93 | 0.54 | 0.70 | 0.73 | 0.36 | 0.47 | 0.49 | 1.15 |
| Total Assets | 49.01 | 56.99 | 65.00 | 66.97 | 85.97 | 106 | 116 | 129 | 131 | 132 | 128 | 127 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 4.99 | 8.97 | 9.97 | 10.97 | 11.96 | 6.98 | 14.94 | 9.96 | 5.98 | 8.97 | 10.97 | 4.98 |
| Cash from investing activity | −5.01 | −13.03 | −10.02 | −7.02 | −17.04 | −16.03 | −17.04 | −13.04 | −3.01 | −7.02 | −4.01 | −6.01 |
| Cash from financing activity | 0.00 | 3.01 | 0.00 | −4.01 | 5.01 | 8.02 | 2.01 | 3.01 | −3.01 | −1.01 | −7.02 | 1.01 |
| Net cash flow | 0.00 | −0.99 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capex | 5.13 | 13.39 | 10.32 | 6.70 | 17.26 | 15.94 | 16.59 | 12.93 | 3.18 | 7.13 | 3.69 | 5.89 |
| Free cash flow | 0.00 | −3.99 | 0.00 | 3.99 | −5.98 | −8.98 | −1.99 | −2.99 | 2.99 | 0.99 | 6.98 | −0.99 |
| CFO / OP % | 119.1% | 165.0% | 119.1% | 102.0% | 84.1% | 61.1% | 110.0% | 99.1% | 72.0% | 167.0% | 93.1% | 78.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 25 | 23 | 25 | 23 | 27 | 30 | 25 | 22 | 27 | 31 | 31 | 21 |
| Inventory days | 62 | 61 | 67 | 50 | 103 | 173 | 172 | 165 | 144 | 141 | 176 | 159 |
| Days payable | 33 | 21 | 41 | 34 | 46 | 54 | 37 | 85 | 79 | 65 | 72 | 46 |
| Cash conversion cycle | 54 | 63 | 51 | 39 | 84 | 149 | 160 | 102 | 92 | 107 | 135 | 135 |
| Working capital days | 12 | −15 | −17 | −4 | 3 | 12 | 0 | 0 | 10 | −4 | 5 | 48 |
| ROCE % | 8.0% | 10.0% | 13.0% | 16.0% | 22.0% | 16.0% | 10.0% | 4.0% | 3.0% | 0.0% | 5.0% | 0.0% |
For the Mar 2026 quarter, Kothari Fermentation & Biochem reported sales of ₹32.41 Cr, up 1.0% year on year and net profit of ₹1.26 Cr, up 21.2% year on year. The operating margin was 9.0%.
Kothari Fermentation & Biochem's sales for the year to Mar 2026 were ₹112 Cr; over the last twelve months they were ₹112 Cr.
Net profit for the year to Mar 2026 was −₹2.99 Cr, and −₹3.29 Cr over the last twelve months. Earnings per share over the same trailing period were ₹−2.18.
Kothari Fermentation & Biochem reported borrowings of ₹47.85 Cr at Mar 2026, against cash and equivalents of ₹1.15 Cr.
Cash from operations was ₹4.98 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹0.99 Cr.